Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab vs Triamcinolone for BRVO
NCT01044329Phase 2Unknown
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jan 2010
- Primary completion
- Aug 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in branch retinal vein occlusion (BRVO), sponsored by Shahid Beheshti University of Medical Sciences. Status: unknown.
02
Drugs
bevacizumab
03
Conditions
branch retinal vein occlusion (BRVO)
Beyond the preview
Go deeper on NCT01044329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01044329.